- £29.37bn
- £32.71bn
- $6.62bn
- 86
- 11
- 91
- 71
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,861 | 5,179 | 5,372 | 6,288 | 6,619 |
Cost of Revenue | |||||
Gross Profit | 4,216 | 4,426 | 4,511 | 5,288 | 5,549 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,713 | 4,008 | 4,200 | 4,871 | 5,355 |
Operating Profit | 1,148 | 1,171 | 1,172 | 1,417 | 1,264 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 957 | 942 | 1,077 | 1,447 | 1,174 |
Provision for Income Taxes | |||||
Net Income After Taxes | 701 | 679 | 802 | 1,151 | 773 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 695 | 675 | 803 | 1,165 | 770 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 695 | 675 | 803 | 1,165 | 770 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.851 | 0.908 | 1.01 | 1.38 | 1.19 |
Dividends per Share |